偉能集團(01608.HK)就兩個斯里蘭卡發電項目簽訂購電協議
偉能集團(01608.HK)公布,集團近日就兩個位於斯里蘭卡的發電項目簽訂購電協議,預計總裝機容量為38.8兆瓦,發電站預計於2020年3月底投入營運。連同已續約的54.9兆瓦裝機容量,集團於當地的總裝機容量將接近100兆瓦。
偉能集團首席商務官張陽表示,公司於2019年4月首次進入斯里蘭卡的電力市場,利用快捷交付的分佈式發電方案彌補當地的電力短缺。在短短一年時間內,再次獲得新項目,不但進一步證明集團在業內的實力和專業,更突顯分佈式發電的優勢。公司將繼續滿足當地居民的需求,提供更多可靠、穩定的電力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.